Hung‐Ming Wang

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Prospective Study of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography and Magnetic Resonance Imaging in Oral Cavity Squamous Cell Carcinoma With Palpably Negative Neck

Shu‐Hang Ng, Tzu‐Chen Yen, Joseph Tung‐Chieh Chang et al. · Journal of Clinical Oncology · 2006 · 249 citations · Full text

Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET

Shu‐Hang Ng, JosephTung-Chieh Chang, Sheng-Chieh Chan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 178 citations

Neuro-oncology, Nodal Metastases, Nasopharyngeal Cancer +6

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Surgical outcome of T4a and resected T4b oral cavity cancer

Chun‐Ta Liao, Joseph Tung‐Chieh Chang, Hung‐Ming Wang et al. · Cancer · 2006 · 147 citations · Full text